Search research articles
Contact Us
Filters
Showing results (71-80 of 296) with videos related to
Page
of 30
Sort By:
Fertility and Sterility
|
December 13, 2002
Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium
Rosalyn D Blumenthal, Alice P Taylor, Lisa Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2005
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
David M Goldenberg, Robert M Sharkey, Giovanni Paganelli, et al.
Annals of Surgical Oncology
|
June 16, 2007
Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group
Torsten Liersch, Johannes Meller, Michael Bittrich, et al.
Bioconjugate Chemistry
|
January 26, 2012
New lyophilized kit for rapid radiofluorination of peptides
William J McBride, Christopher A D'Souza, Habibe Karacay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2011
Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys
Thomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
Blood
|
April 18, 2009
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
Edmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Cancer Research
|
September 30, 2010
A bispecific antibody-IFNalpha2b immunocytokine targeting CD20 and HLA-DR is highly toxic to human lymphoma and multiple myeloma cells
Edmund A Rossi, Diane L Rossi, Rhona Stein, et al.
International Journal of Oncology
|
January 15, 2002
Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts
David E Modrak, Marisol D Rodriguez, David M Goldenberg, et al.
Cancer Research
|
April 4, 2002
Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines
Chris Waskewich, Rosalyn D Blumenthal, Honglan Li, et al.
Blood
|
June 17, 2006
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab
Rhona Stein, Zhengxing Qu, Susan Chen, et al.
Page
of 30
Search research articles
Search
Showing results (71-80 of 296) with videos related to
Sort By:
Page
of 30
Fertility and Sterility
|
December 13, 2002
Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium
Rosalyn D Blumenthal, Alice P Taylor, Lisa Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2005
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
David M Goldenberg, Robert M Sharkey, Giovanni Paganelli, et al.
Annals of Surgical Oncology
|
June 16, 2007
Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group
Torsten Liersch, Johannes Meller, Michael Bittrich, et al.
Bioconjugate Chemistry
|
January 26, 2012
New lyophilized kit for rapid radiofluorination of peptides
William J McBride, Christopher A D'Souza, Habibe Karacay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2011
Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys
Thomas M Cardillo, Serengulam V Govindan, Robert M Sharkey, et al.
Blood
|
April 18, 2009
Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma
Edmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.
Cancer Research
|
September 30, 2010
A bispecific antibody-IFNalpha2b immunocytokine targeting CD20 and HLA-DR is highly toxic to human lymphoma and multiple myeloma cells
Edmund A Rossi, Diane L Rossi, Rhona Stein, et al.
International Journal of Oncology
|
January 15, 2002
Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts
David E Modrak, Marisol D Rodriguez, David M Goldenberg, et al.
Cancer Research
|
April 4, 2002
Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines
Chris Waskewich, Rosalyn D Blumenthal, Honglan Li, et al.
Blood
|
June 17, 2006
Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab
Rhona Stein, Zhengxing Qu, Susan Chen, et al.
Page
of 30